| DLQI‐R scoring improves the discriminatory power of the Dermatology Life Quality Index in patients with psoriasis, pemphigus and morphea F Rencz, L Gulácsi, M Péntek, A Szegedi, É Remenyik, Z Bata‐Csörgő, ... British Journal of Dermatology 182 (5), 1167-1175, 2020 | 38 | 2020 |
| Validity of the EQ‐5D in patients with pemphigus vulgaris and pemphigus foliaceus B Tamási, V Brodszky, M Péntek, L Gulácsi, K Hajdu, M Sárdy, A Szegedi, ... British Journal of Dermatology 180 (4), 802-809, 2019 | 37 | 2019 |
| Immune-mediated skin inflammation is similar in severe atopic dermatitis patients with or without filaggrin mutation Z Dajnoki, G Béke, G Mócsai, A Kapitány, K Gáspár, K Hajdu, G Emri, ... Acta dermato-venereologica 96 (5), 645-650, 2016 | 26 | 2016 |
| Improvement of clinical and immunological parameters after allergen‐specific immunotherapy in atopic dermatitis K Hajdu, A Kapitány, Z Dajnoki, L Soltész, S Baráth, Z Hendrik, I Veres, ... Journal of the European Academy of Dermatology and Venereology 35 (6), 1357-1361, 2021 | 22 | 2021 |
| Disease burden of patients with pemphigus from a societal perspective V Brodszky, B Tamási, K Hajdu, M Péntek, A Szegedi, M Sárdy, ... Expert review of pharmacoeconomics & outcomes research 21 (1), 77-86, 2021 | 20 | 2021 |
| Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis K Koszorú, K Hajdu, V Brodszky, A Bató, LH Gergely, A Kovács, ... The European Journal of Health Economics 24 (1), 139-152, 2023 | 19 | 2023 |
| Dermatology Life Quality Index (DLQI) score bands are applicable to DLQI-Relevant (DLQI-R) scoring F Rencz, LH Gergely, N Wikonkál, K Gáspár, M Péntek, L Gulácsi, ... Journal of the European Academy of Dermatology and Venereology: JEADV 34 (9 …, 2020 | 16 | 2020 |
| General and skin-specific health-related quality of life in patients with atopic dermatitis before and during the COVID-19 pandemic K Koszorú, K Hajdu, V Brodszky, Á Szabó, J Borza, K Bodai, G Pónyai, ... Dermatitis 33 (6S1), S92-S103, 2022 | 15 | 2022 |
| Patient‐assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceus K Hajdu, V Brodszky, PFM Stalmeier, G Ruzsa, B Tamási, L Gulácsi, ... Journal of the European Academy of Dermatology and Venereology 33 (11), 2106 …, 2019 | 14 | 2019 |
| Subjective well-being in patients with pemphigus: a path analysis A Mitev, F Rencz, B Tamási, K Hajdu, M Péntek, L Gulácsi, A Szegedi, ... The European Journal of Health Economics 20, 101-107, 2019 | 11 | 2019 |
| Societal costs and health related quality of life in adult atopic dermatitis Z Beretzky, K Koszorú, F Rencz, K Hajdu, J Borza, K Bodai, X Feifei, ... BMC Health Services Research 23 (1), 859, 2023 | 3 | 2023 |
| A simple, combined test can improve the diagnosis of autoimmune urticaria K Hajdu, B Irinyi, E Gyimesi, A Kapitány, Z Dajnoki, Z Bata‐Csörgő, ... British Journal of Dermatology 177 (3), 864-866, 2017 | 3 | 2017 |
| Az atópiás dermatitis új terápiás lehetőségei K Steuer-Hajdu, A Szegedi | 2 | 2021 |
| 080 The impact of atopic dermatitis on health-related quality of life K Koszorú, K Hajdu, J Borza, K Bodai, Á Szabó, A Bató, A Szegedi, ... Journal of Investigative Dermatology 141 (10), S162, 2021 | 1 | 2021 |
| New therapies in atopic dermatitis. K Steuer-Hajdu, S Andrea | 1 | 2021 |
| 673 Cost-of-illness of adult atopic dermatitis in Hungary K Koszorú, Z Beretzky, F Rencz, K Hajdu, K Blaga, X Feifei, A Szegedi, ... Journal of Investigative Dermatology 143 (5), S116, 2023 | | 2023 |
| Cost-of-illness of adult atopic dermatitis from a societal perspective in Hungary F Rencz, K Hajdu, J Borza, K Bodai, X Feifei, A Szegedi, M Sárdy, ... | | 2023 |
| Cost-of-illness of adult atopic dermatitis from a societal perspective in Hungary Z Beretzky, K Koszorú, F Rencz, K Hajdu, J Borza, K Bodai, X Feifei, ... | | 2023 |
| 082 Comparing psychometric properties of EQ-5D-3L and EQ-5D-5L in atopic dermatitis K Koszorú, K Hajdu, V Brodszky, A Bató, LH Gergely, A Kovács, ... Journal of Investigative Dermatology 142 (12), S194, 2022 | | 2022 |
| Cutaneous metastases at the sites of pembrolizumab-induced bullous pemphigoid lesions in a patient with melanoma B Ványai, YCC Chien, L Beke, IL Szabó, Z Péter, K Steuer-Hajdu, ... Immunotherapy 14 (17), 1377-1382, 2022 | | 2022 |
